Clinical Trials in Arizona

Showing 11341-11360 of 16,770 trials

COMPLETEDPhase 131 miles

Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer

NCT00415636

The purpose of this study is to evaluate the safety and tolerability of IC83/LY2603618 for the treatment of cancer.

Cancer

Eli Lilly and Company31 participantsStarted Jan 2007

Scottsdale, Arizona, United States

COMPLETEDPhase 335 miles

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

NCT00975000

Hyperparathyroidism (HPT) is common in people with a kidney transplant. Patients with HPT often have high parathyroid hormone (PTH) levels and may have large parathyroid glands in the neck. Patients with HPT can develop bone disease (osteodystrophy). This bone disease can cause bone pain, fractures, and poor formation of red blood cells. Other problems from HPT may include increases in blood levels of calcium (hypercalcemia) and low blood levels of phosphorus (hypophosphatemia). The high calcium levels may cause calcium to deposit in body tissues. Calcium deposits can cause arthritis (joint pain and swelling), muscle inflammation, itching, gangrene (death of soft tissue), heart and lung problems or kidney transplant dysfunction (worsening of kidney transplant function). The purpose of this study is to evaluate the effects of cinacalcet (Sensipar/Mimpara) on high calcium levels in the blood in patients with HPT after a kidney transplant.

Chronic Allograft NephropathyChronic Kidney DiseaseChronic Renal Failure+7 more

Amgen114 participantsStarted Dec 2009

Phoenix, Arizona, United States • Tempe, Arizona, United States • San Francisco, California, United States +48 more locations

Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Find Trials by Condition in Arizona

BKM120 for Patients With PI3K-activated Tumors

Irradiated Blood Versus Non Irradiated Blood Transfusions in Craniosynostosis Repair

Long-term Open-Label Safety Study to Evaluate EN3409

A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer

A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

Early Weight-Bearing After Lapidus Arthrodesis

Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods

A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).